Stimulation of cell proliferation caused by peroxisome proliferators was blocked by antibodies against TNFα and agents that inactivate Kupffer cells, a rich source of TNFα, which supports the hypothesis that Kupffer cells play a pivotal role in peroxisome proliferator-induced hyperplasia. Here, the ability of the very potent peroxisome proliferator WY-14 643 to activate the transcription factor NF-κB in rat liver was examined since it is involved in TNFα production. Female Sprague-Dawley rats were treated by gavage with WY-14 643 (100 mg/kg) while control animals were given equivalent doses of vehicle (olive oil). Activation of NF-κB in both whole liver, non-parenchymal cells, Kupffer cells and hepatocytes was assessed for up to 36 h using an electrophoretic mobility shift assay. In whole liver, WY-14 643 transiently increased NF-κB binding maximally 3.5-fold in 2-8 h followed by a steady decline to near control levels at 36 h. As early as 2 h after WY-14 643 treatment, the active form of NF-κB was localized predominantly in Kupffer cells with values 20-to 25-times greater than in hepatocytes. In hepatocytes, a small increase in NF-κB binding was observed but only 8 h after WY-14 643 administration. Pre-treatment with allopurinol, a xanthine oxidase inhibitor and free radical scavenger, suppressed NF-κB activation by WY-14 643 almost completely. It is concluded that NF-κB is activated by reactive oxygen species and plays a central role in the mechanism of action of peroxisome proliferators. Moreover, these findings support the hypothesis that Kupffer cells play a pivotal role in peroxisome proliferator-induced hepatocyte proliferation through rapid NF-κB activation and subsequent induction of TNFα production. TNFα from Kupffer cells stimulates growth in parenchymal cells later via mechanisms that also involve NF-κB.
Introduction
The transcription factor nuclear factor (NF*)-κB plays an essential role in the regulation of a variety of genes involved *Abbreviations: DMEM, Dulbecco's modified Eagle's medium; FBS, fetal bovine serum; HBSS, Hanks' balanced salt solution; IL, interleukin; LPS, lipopolysaccharide; NF-κB, nuclear factor κB; PKC, protein kinase C; TNFα, tumor necrosis factor α; WY-14 643, 4-chloro-6-(2,3-xylidino)pyrimidinylthioacetic acid.
in inflammatory responses, immune function and control of cell growth and differentiation (1) (2) (3) . NF-κB is a set of homoand heterodimeric complexes composed of members of the Rel/NF-κB family of proteins, which are characterized by a conserved N-terminal domain of~300 amino acids known as the Rel homology domain. This domain participates in DNA binding, dimerization and binding to inhibitory proteins (3) .
In most cell types, NF-κB is normally present in an inactive form in the cytoplasm through its physical association with inhibitory proteins (IκBα or IκBβ) (2) . Typically, NF-κB is rapidly activated in response to immunological stimuli such as lipopolysaccharide (LPS), cytokines such as tumor necrosis factor (TNF)α or interleukin (IL)-1, and B-or T-cell activation (1) . A variety of other stimuli also lead to NF-κB activation, including free radicals, mitogens, viral infection and UV irradiation (3) . Moreover, activation of NF-κB is under the control of oxidant/antioxidant regulatory system; therefore, reactive oxygen species play a central role in gene expression (4) . Activation of NF-κB occurs via a mechanism that involves the rapid phosphorylation and proteolytic degradation of IκB, which leads to the release and nuclear translocation of active NF-κB dimers (1) .
Peroxisome proliferators are a group of structurally diverse compounds used extensively in the chemical and pharmaceutical industries. They have been shown to cause proliferation of hepatic peroxisomes, hyperplasia of hepatocytes and liver enlargement because of increased cell proliferation and hepatocyte hypertrophy (5, 6) . These compounds also cause a high incidence of hepatocellular carcinoma in rodents. Indeed, WY-14 643, one of the most potent peroxisome proliferators with hypolipidemic properties, produced 100% tumors after 16 months of exposure in rats (5, 6) .
Many hypotheses have been proposed to explain the mechanisms of hepatocarcinogenicity of peroxisome proliferators, including the 'oxidative stress hypothesis' (7). It was suggested that peroxisome proliferation leads to increased production of hydrogen peroxide and subsequent oxidative DNA damage (8) . However, this idea has been contested in part because of lack of correlation between presence of markers of oxidative DNA damage (e.g. 8-hydroxy-2Ј-deoxyguanosine) in the liver and the incidence of tumors after treatment with potent peroxisome proliferators (9) . On the other hand, WY-14 643 causes a sustained increase in rates of cell replication (5) . Further, an elevated carcinogenic response to a peroxisome proliferator in older animals was observed, which supports the hypothesis that WY-14 643 may promote tumor formation from previously initiated cells (10) .
Kupffer cells are one of the major sources of mitogenic stimuli in liver (e.g. TNFα, prostaglandin E 2 , hepatocyte growth factor) (11, 12) . Moreover, nafenopin and WY-14 643 stimulated particle phagocytosis by Kupffer cells in vivo, which could lead to release of cytokines and stimulate hepatocyte growth (13) . In addition, hepatocyte proliferation induced by WY-14 643 was prevented by inactivation of Kupffer cell production of TNFα with methyl palmitate (14) and glycine (15) , or by administration of antibodies to TNFα (16) .
Dietary feeding of ciprofibrate increased NF-κB activity in rat whole liver nuclear extracts after 3 days of feeding (17) , whereas nafenopin or BR-931 had no effect after a single dose for up to 24 h (18, 19) . It is possible, however, that much earlier events could be present since a burst in cell replication in liver occurs within hours of treatment with peroxisome proliferators (5) . Since Kupffer cells are implicated in increased cell proliferation via mechanisms that involve TNFα, these experiments were designed to test the hypothesis that peroxisome proliferators stimulate proliferation of hepatocytes via early activation of the transcription factor NF-κB in Kupffer cells, which leads to increased TNFα production.
Materials and methods

Animals
Female Sprague-Dawley rats weighing 175-225 g were used in all experiments. Animals were housed 2-3 per cage with a 12 h day-night cycle and given laboratory chow and water ad libitum. Animals were acclimated for at least 1 week before treatment, and Institutional Animal Care and Use Committee criteria were followed. WY-14 643 [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio acetic acid] was obtained from Chemsyn Science Laboratories (Lenexa, KS). All other chemicals and reagents were of the highest available purity from standard commercial sources (Sigma, St Louis, MO) unless otherwise stated. Rats were given a single dose of WY-14 643 (100 mg/kg) in olive oil (0.4 ml) i.g., and control rats received equal amounts of vehicle. Some animals were also pre-treated 24 and 1 h before WY-14 643 with 100 mg/kg of allopurinol i.g. (Sigma, St Louis, MO) dissolved in physiological saline, whereas control animals received saline only. Treatments were performed between 9 a.m. and noon and rats were killed under pentobarbital anesthesia at different time intervals that ranged from 1 to 36 h. Livers were perfused briefly with Hanks' balanced salt solution (HBSS), frozen in liquid nitrogen and stored at -80°C before experiments or cell isolation as described below.
Cell isolation
Hepatocyte, non-parenchymal and Kupffer cell fractions were prepared by collagenase digestion and differential centrifugation using Percoll (Pharmacia, Uppsala, Sweden) as described elsewhere with slight modifications (20) . Briefly, livers were perfused in situ through the portal vein with Ca 2ϩ -and Mg 2ϩ -free HBSS (138 mM NaCl, 5.4 mM KCl, 0.3 mM Na 2 HPO 4 , 0.4 mM KH 2 PO 4 , 5.6 mM glucose, 4 mM NaHCO 3 , 0.5 mM EGTA) at 37°C for 5 min at a flow rate of 25 ml/min. Subsequently, perfusion was with HBSS (composition as above with 0.4 mM MgSO 4 and 1.26 mM CaCl 2 added, and EGTA excluded) that contained 0.025% collagenase IV (Sigma) at 37°C for 5 min at the same flow rate. After perfusion, the liver was excised and dissected in collagenase-containing HBSS. The suspension was filtered through nylon gauze and the filtrate was centrifuged at 450 g for 10 min at 4°C. Cell pellets were resuspended in buffer, and parenchymal cells were removed by centrifugation at 50 g for 3 min and used for preparation of nuclear extracts as described below. The non-parenchymal cell fraction was washed twice with buffer. Cells were centrifuged on a double layer of Percoll (25 and 50%, 15 and 20 ml each, respectively) at 1000 g for 15 min and the Kupffer cell fraction was collected and washed with buffer. To obtain pure Kupffer cells, cells were seeded onto Petri dishes and cultured for 1 h in Dulbecco's modified Eagle's medium (DMEM-L, 1000 mg/l glucose) supplemented with 10% fetal bovine serum (FBS) and antibiotics (100 U/ml of penicillin G and 100 µg/ml of streptomycin sulfate). Non-adherent cells were removed by replacing media with fresh DMEM-L culture medium. Adherent Kupffer cells were collected and used for preparation of nuclear extracts. Viability was determined by trypan blue exclusion and was above 90%.
Preparation of nuclear extracts
Hepatocytes and non-parenchymal cells were washed with cold HBSS twice. Cultured Kupffer cells were harvested with a cell scraper, washed and centrifuged at 1500 g for 5 min. Further isolation was performed on ice as described by Dignam et al. (21) with minor modifications. Briefly, after decanting the supernatant, the packed cell volume was measured and used to estimate buffer volumes. Five vols of ice-cold buffer A (10 mM HEPES, pH 7.6, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT) supplemented with proteinase and phosphatase inhibitors (40 µg/ml bestatin, 20 mM β-glycerophosphate, 10 mM PNPP, 0.5 mM pefabloc, 0.7 µg/ml pepstatin A, 2 µg/ml aprotinin, 1218 50 µM Na 3 VO 4 and 0.5 µg/ml leupeptin) was added, cells were resuspended with a 1000 µl pipette tip and allowed to swell on ice for 15 min. Aliquots of 25 µl of 10% NP-40 (Sigma) were added and each aliquot was vortexed for~10 s. The homogenate was centrifuged at top speed for 30 s in a microfuge. The supernatant was discarded and the nuclear pellet was lysed in 0.2 vol. of ice-cold buffer C (10 mM HEPES, pH 7.6, 1.5 mM MgCl 2 , 0.42 M NaCl, 25% glycerol, 0.5 mM DTT, 0.2 mM EDTA) supplemented with proteinase and phosphatase inhibitors, while tubes were rocked vigorously for 15 min at 4°C. Nuclear extracts were centrifuged for 5 min at 4°C, supernatants were collected, frozen in liquid nitrogen and stored at -80°C prior to experiments. Protein concentration was determined using the Bradford Protein Concentration Assay Kit (Bio-Rad, Hercules, CA) by measuring absorbance spectrophotometrically at 595 nm (22) .
For studies in whole liver, 200-300 mg of frozen tissue was placed on a 10 cm Petri dish on ice and minced immediately before the isolation procedure. All subsequent steps were performed on ice. The minced tissue was placed into a 2 ml vial that contained 1 ml of buffer A and was vortexed several times. After centrifugation for 5 s at top speed, the supernatant was collected, transferred into a Kontes 2 ml homogenizer and lysed with 2-3 strokes of the pestle. The homogenate was collected, placed into a 2 ml vial and allowed to swell on ice for 15 min. Subsequently, all steps for the procedure described above for cells were followed.
Electrophoretic mobility shift assay
The gel mobility shift assay was used in this study to assess the amount of active protein involved in protein-DNA interactions. The limitations of this method are the amount of nuclear protein needed for assay, as well as the number of cells isolated from the rat liver. There are alternative approaches available, such as fluorescein end-labeled oligonucleotides to avoid use of radioactivity, and transient transfection of cells with an NF-κB-dependent luciferase reporter gene.
Binding conditions for NF-κB were characterized and electrophoretic mobility shift assays performed as described in detail elsewhere (23) . Briefly, 8-40 µg of nuclear extract from cells or liver tissue were pre-incubated for 10 min on ice with 1 µg poly(dI-dC) and 20 µg BSA (both from Pharmacia Biotech, Piscataway, NJ) in a buffer that contained 1 mM HEPES (pH 7.6), 40 mM MgCl 2 , 0.1 M NaCl, 8% glycerol, 0.1 mM DTT, 0.05 mM EDTA and 2 µl of a 32 P-labeled DNA probe (10 000 c.p.m./µl; Cerenkov) that contained 0.4 ng of double-stranded oligonucleotide. Mixtures were incubated 20 min on ice and resolved on 5% polyacrylamide (29:1 cross-linking) and 0.4ϫ TBE gels. After electrophoresis, gels were dried and exposed to Kodak film. Specificity of NF-κB binding was verified by competition assays and ability of specific antibodies to supershift protein-DNA complexes. In competition assays, 100-fold excess of unlabeled oligonucleotide was added 10 min before addition of the labeled probe. In supershift experiments, 1 µl of rabbit antisera against p50 protein (Santa Cruz Biotech, Santa Cruz, CA) was added to the reaction mixture after incubation with labeled probe, which was further incubated at 25°C for 30 min. Labeled and unlabeled oligonucleotides contained the consensus sequence for NF-κB (top strand: 5Ј-GCAGAGGGGACTTTCCGGA-3Ј; bottom strand: 5Ј-GTCTGCCAAAGTC-CCCTCTG-3Ј) (24) . Data were quantitated by scanning autoradiograms with GelScan XL (Pharmacia LKB, Uppsala, Sweden). Statistics Results are reported as means Ϯ SEM with n ϭ 4-5 in each group. Treatment groups were compared using Kruskal-Wallis one-way ANOVA on ranks using Dunn's post-hoc test, one-way ANOVA followed by Tukey's post-hoc test, or two-way ANOVA using Tukey's post-hoc test, where appropriate. A P-value Ͻ0.05 was selected prior to the study to determine statistical differences between groups.
Results
WY-14 643 increases activity of NF-κB in hours
The effect of an acute WY-14 643 treatment (100 mg/kg, i.g.) on NF-κB binding activity in whole rat liver nuclear extracts is shown in Figure 1 . The active form of NF-κB was barely detectable in livers of animals fed a regular chow diet; however, it was elevated by 2 and 8 h after treatment with WY-14 643. Olive oil, which was used as the vehicle, had a very small but detectable effect on NF-κB activity but only 2 h after treatment. The time-dependent effect of treatment with WY-14 643 on the activity of NF-κB in whole rat liver is shown in Figure 2 . Activity of NF-κB was transient with a rapid maximal increase of 3.5-fold over that of vehicle-treated controls. This was observed between 2 and 8 h after treatment and was followed by a steady decline to near control levels by 36 h (Figure 2B) .
In order to confirm that protein binding in nuclear extracts to labeled oligonucleotide probe was specific for the active form of NF-κB, gel shift assays were carried out either in the presence of an excess of unlabeled double-stranded oligonucleotide with a consensus sequence for NF-κB binding, or with antibodies specific for the NF-κB p50 subunit (Figure 3 ). In the absence of nuclear proteins, no protein-DNA complex was detected (lane 1). Moreover, unlabeled oligonucleotide that contained the NF-κB binding site could effectively compete for DNA binding with a 32 P-labeled probe (lanes 2 and 3) in the presence of an excess of unlabeled competitor (lanes 4 and 5). Moreover, addition of anti-p50 antiserum reduced the intensity of the complex and produced supershifted complexes with a higher molecular mass (lane 6). 4) were incubated with 32 P-labeled double-stranded oligonucleotide encompassing the κB motif. Lane 1 shows labeled probe with no nuclear extract added. In competition assays (lanes 4 and 5), 100-fold excess of unlabeled oligonucleotide was used. In a supershift experiment (lane 6), 1 µl of rabbit antisera against p50 protein was added. Positions of the native NF-κB/DNA complex, supershifted complex of labeled oligonucleotide, active NF-κB and p50 antibody are indicated by labeled arrows. were isolated and nuclear extracts prepared. Equal amounts (20 µg) of nuclear extracts were incubated with 32 P-labeled double-stranded oligonucleotide encompassing the κB motif. Representative autoradiogram. (B) Data are results of densitometry analysis (mean Ϯ SEM) of the NF-κB-DNA complex images from four separate experiments performed as described in (A). Asterisks (*) denote statistical differences from corresponding control group (P Ͻ 0.05) by one-way ANOVA followed by Tukey's post-hoc test. NF-κB activity in non-treated animals and animals treated with WY-14 643 for 0 h was equal (data not shown).
Early activation of NF-κB in rat liver by WY-14 643 occurs predominantly in Kupffer cells
Animals were treated with WY-14 643, and non-parenchymal and parenchymal cells were obtained at various time intervals from 0 to 36 h ( Figure 4A ). NF-κB activity was elevated~3- Density of the NF-κB/DNA complex images of non-treated rats (CON) was set to 100%. Asterisk (*) denotes statistical difference from control group (P Ͻ 0.05) by one-way ANOVA using Tukey's post-hoc test.
fold at 2-8 h after WY-14 643 treatment in the non-parenchymal cell fraction and then declined toward basal values, which is similar to what occurred in whole liver. In contrast, hepatocytes exhibited maximal activity only after 8 h, which was~6-fold less than in non-parenchymal cells. Importantly, at 2 h after WY-14 643 treatment, the active form of NF-κB was localized almost exclusively in non-parenchymal cells with values that were 20-to 25-times greater than in hepatocytes ( Figure 4B ).
To determine if the increase in non-parenchymal cells was caused by Kupffer cells, they were purified. The active form of NF-κB was localized in Kupffer cells 2 h after treatment with WY-14 643 (Figure 5, WY) . While some NF-κB was present in Kupffer cells from rats treated with vehicle for 2 h (VEH), almost none was observed in Kupffer cells from naive animals (CON).
Allopurinol abolishes the rapid activation of NF-κB by WY-14 643 in rat liver
To determine if antioxidants could prevent rapid activation of NF-κB caused by a single dose of WY-14 643, rats were pretreated with either allopurinol (100 mg/kg) or saline at 24 and 1 h before administration of WY-14 643 or vehicle. Allopurinol is both a free radical scavenger and an inhibitor of xanthine oxidase (25) . Pre-treatment with allopurinol prevented the rapid activation of NF-κB caused by WY-14 643 almost completely ( Figure 6 , WY ϩ AL). In naive animals treated with WY-14 643, NF-κB activity increased 3.5-fold (WY), whereas pre-treatment with allopurinol alone had no effect (AL).
Discussion
Kupffer cells are an early target of WY-14 643
WY-14 643, a very potent peroxisome proliferator and rodent carcinogen (5), activated nuclear transcription factor κB in rat liver by~3.5-fold as early as 2 h after a single dose ( Figure  1) . Importantly, the active form of NF-κB was localized predominantly in Kupffer cells with values that were 20-to 25-times greater than in hepatocytes (Figures 4 and 5) . The activation of NF-κB was time-dependent with a peak at 2-8 h, followed by a steady decline to basal levels by 36 h (Figure 2) . Binding of nuclear proteins to labeled doublestranded oligonucleotide that encompassed the κB motif was specific ( Figure 3) .
Recently, it has been reported that treatment with ciprofibrate, nafenopin and BR 931 (17) (18) (19) , which are less potent peroxisome proliferators than WY-14 643, either increased liver NF-κB activity only after 3 days of feeding (17) , or had no effect for up to 24 h (18, 19) . In the present study, it is clear that much earlier activation of NF-κB occurs when a more potent peroxisome proliferator (i.e. WY-14 643) was evaluated.
It is known that peroxisome proliferators can induce peroxisomes directly in hepatocytes (26) ; however, recent data support the hypothesis that Kupffer cells play a pivotal role in increased cell proliferation. For example, Kupffer cells are a rich source of a variety of mitogenic cytokines (15) such as TNFα, which can trigger cell growth in nearby hepatocytes (27) . Moreover, glycine (15) and methyl palmitate (14) , which both inactivate Kupffer cell TNFα production via different mechanisms, as well as an antibody to TNFα (16), completely prevented stimulation of hepatocyte proliferation caused by WY-14 643. Since Kupffer cells are implicated in this process via mechanisms that involve TNFα, and TNFα synthesis is NF-κB dependent, it was hypothesized that proliferation of hepatocytes is stimulated via early activation of the transcription factor NF-κB in Kupffer cells, which leads to increased TNFα production that triggers subsequent proliferation in hepatocytes. The present findings showed that activation of NF-κB by WY-14 643 occurs very early, but first and more robustly in Kupffer cells ( Figure 5 ). Subsequently, but much more weakly, NF-κB is activated in hepatocytes (Figure 4 ). These exciting data support the hypothesis that Kupffer cell NF-κB acts as a trigger of cell proliferation in rodent liver because of treatment with peroxisome proliferators.
NF-κB may play a central role in the mechanism of nongenotoxic carcinogenesis induced by WY-14 643
Several hypotheses have been proposed to account for the mechanism by which peroxisome proliferators cause hepatocellular adenomas and carcinomas in rodents. Some have suggested that oxidative stress is a major event (7), whereas others favor the idea that enhanced cell replication and promotion of previous lesions are causal for hepatic cancer (5, 28) . Whatever the precise mechanism, it is likely that increased cell replication plays a central role in this process (5) . Initiation of parenchymal cells in liver could be caused by sustained oxidative stress, spontaneous mutation or unrepaired DNA damage because of increased rates of cell turnover (29) .
The NF-κB complex is activated by phosphorylation and ubiquitination, and is followed by proteosomal degradation of the IκB component, which enables the p50/p65 heterodimer to translocate to the nucleus and bind specific DNA sequences (for a review, see ref. 1). Because peroxisome proliferators are non-genotoxic compounds, it was reasoned that they act in a manner analogous to tumor promoters via protein kinase C (PKC), a second messenger system that signals cell proliferation and is elevated during increased cell turnover (30) . PKC is involved in the process of activation of NF-κB via two separate pathways. It is known that the ζ isoform of PKC can phosphorylate IκB (31) . Further, PKC can indirectly increase production of oxidants (e.g. superoxide anion), which are redox modulators of NF-κB activity, by phosphorylation of NADPH oxidase (reviewed in ref. 32 ). Indeed, WY-14 643 increased PKC by 3-fold in 5 h and 5-fold in 10 h in vivo, and inhibited acyl CoA synthetase in a competitive manner in vitro (33) . Inhibition of acyl CoA synthetase by peroxisome proliferators could lead to elevation of free fatty acids, which are known activators of PKC (34) .
Other reactive oxygen species generating systems could also be involved. It is known that Kupffer cells contain significant amounts of xanthine oxidase, which responds much faster to stress than the enzyme in hepatocytes (35) . Indeed, pretreatment with the xanthine oxidase inhibitor and radical scavenger allopurinol blocked activation of NF-κB by WY-14 643 at 2 h ( Figure 6 ). Since nearly all of the increase in active NF-κB is because of Kupffer cells at this time ( Figure 5 ), it is concluded that Kupffer cell-derived oxidants are causal in WY-14 643-induced activation of NF-κB.
Since hepatocytes are the dominant cell type in the liver in terms of size and number, later activation of NF-κB in hepatocytes, observed here, occurs most likely as a consequence of TNFα production after activation of Kupffer cells. Binding of TNFα to its receptor and induction of a chain of intracellular events can indeed activate NF-κB in hepatocytes (36) . This, in turn, is known to stimulate cell proliferation in the liver (37) .
The data presented here support the hypothesis that activation of nuclear transcription factor κB in Kupffer cells is a key early event that results in the subsequent increase of TNFα, which leads to increased cell proliferation in the liver.
